Metabesity 2020

David Fox moderated the session titled "Is Aging a Disease?" at Metabesity 2020.

Tokyo: Life Sciences and Health Care Horizons 2019

Key Life Sciences issues for Japanese companies: focus on (1) digital health, (2) cell, tissue, and gene therapies, and (3) cross-border transactions.

Early Interactions With FDA and Developing the Value Story for Your Innovative Product

David Fox, Randy Prebula, Beth Roberts, and Susan Lee will be speakers at the Harvard Innovation Labs. They will have an interactive discussion that will cover:

Biosimilars: the revolution is underway, where do you stand?

The eighth edition of our Life Sciences seminar will be held on 31 March and will focus on biosimilars. Biological medicines now account for 20% of the pharmaceutical market in the world...

Brands, Generics, and Hatch-Waxman-New Challenges: Unabated Controversy

The Drug Price Competition and Patent Term Restoration Act of 1984, known as the Hatch-Waxman Amendments, continues to be the most litigated and generally contentious arenas of drug law....

Loading data